Global mRNA Vaccines Industry Research and Trends Report 2020-2026

1 Report Overview

　1.1 Study Scope

　1.2 Key Market Segments

　1.3 Players Covered: Ranking by mRNA Vaccines Revenue

　1.4 Market Analysis by Type

　　1.4.1 Global mRNA Vaccines Market Size Growth Rate by Type: 2020 VS 2026

　　1.4.2 Being Developed

　　1.4.3 Preclinical

　　1.4.4 Clinical I

　　1.4.5 Clinical II

　1.5 Market by Application

　　1.5.1 Global mRNA Vaccines Market Share by Application: 2020 VS 2026

　　1.5.2 COVID-19

　　1.5.3 Cancer

　　1.5.4 Infectious Disease Treatment MRNA Vaccine

　　1.5.5 Infection Prevention MRNA Vaccine

　1.6 Coronavirus Disease 2019 (Covid-19): mRNA Vaccines Industry Impact

　　1.6.1 How the Covid-19 is Affecting the mRNA Vaccines Industry

　　1.6.1 .1 mRNA Vaccines Business Impact Assessment - Covid-19

　　1.6.1 .2 Supply Chain Challenges

　　1.6.1 .3 COVID-19's Impact On Crude Oil and Refined Products

　　1.6.2 Market Trends and mRNA Vaccines Potential Opportunities in the COVID-19 Landscape

　　1.6.3 Measures / Proposal against Covid-19

　　1.6.3 .1 Government Measures to Combat Covid-19 Impact

　　1.6.3 .2 Proposal for mRNA Vaccines Players to Combat Covid-19 Impact

　1.7 Study Objectives

　1.8 Years Considered

2 Executive Summary

　2.1 mRNA Vaccines Market Perspective (2015-2026)

　2.2 mRNA Vaccines Growth Trends by Regions

　　2.2.1 mRNA Vaccines Market Size by Regions: 2015 VS 2020 VS 2026

轉-載自：http://www.5269660.cn/7/83/Global-mRNA-Vaccines-Industry-Research-and-Trends-Report-2020-2026.html

　　2.2.2 mRNA Vaccines Historic Market Share by Regions (2018-2019)

　2.3 Industry Trends and Growth Strategy

　　2.3.1 Market Top Trends

　　2.3.2 Market Drivers

3 Competition Landscape by Key Players

　3.1 mRNA Vaccines Revenue by Players (2019-2020)

　3.2 mRNA Vaccines Key Players Head office and Area Served

　3.3 Key Players mRNA Vaccines Product/Solution/Service

　3.4 Date of Enter into mRNA Vaccines Market

　3.5 Key Players mRNA Vaccines Funding/Investment Analysis

　3.6 Global Key Players mRNA Vaccines Valuation & Market Capitalization

　3.7 Mergers & Acquisitions, Expansion Plans

4 Global mRNA Vaccines Market Size by Type (2019-2026)

5 Global mRNA Vaccines Market Size by Application (2019-2026)

6 North America

　6.1 North America mRNA Vaccines Market Forecast (2019-2026)

　6.2 mRNA Vaccines Key Players in North America (2019-2020)

　6.3 North America mRNA Vaccines Market Size by Type (2015-2020)

　6.4 North America mRNA Vaccines Market Size by Application (2015-2020)

7 Europe

　7.1 Europe mRNA Vaccines Market Forecast (2019-2026)

　7.2 mRNA Vaccines Key Players in Europe (2019-2020)

　7.3 Europe mRNA Vaccines Market Size by Type (2015-2020)

　7.4 Europe mRNA Vaccines Market Size by Application (2015-2020)

8 China

　8.1 China mRNA Vaccines Market Forecast (2019-2026)

　8.2 mRNA Vaccines Key Players in China (2019-2020)

　8.3 China mRNA Vaccines Market Size by Type (2015-2020)

　8.4 China mRNA Vaccines Market Size by Application (2015-2020)

9 Japan

　9.1 Japan mRNA Vaccines Market Forecast (2019-2026)

　9.2 mRNA Vaccines Key Players in Japan (2019-2020)

　9.3 Japan mRNA Vaccines Market Size by Type (2015-2020)

　9.4 Japan mRNA Vaccines Market Size by Application (2015-2020)

10 Southeast Asia

　10.1 Southeast Asia mRNA Vaccines Market Forecast (2019-2026)

　10.2 mRNA Vaccines Key Players in Southeast Asia (2019-2020)

　10.3 Southeast Asia mRNA Vaccines Market Size by Type (2015-2020)

　10.4 Southeast Asia mRNA Vaccines Market Size by Application (2015-2020)

11 India

　11.1 India mRNA Vaccines Market Forecast (2019-2026)

　11.2 mRNA Vaccines Key Players in India (2019-2020)

　11.3 India mRNA Vaccines Market Size by Type (2015-2020)

　11.4 India mRNA Vaccines Market Size by Application (2015-2020)

12 Central & South America

　12.1 Central & South America mRNA Vaccines Market Forecast (2019-2026)

　12.2 mRNA Vaccines Key Players in Central & South America (2019-2020)

　12.3 Central & South America mRNA Vaccines Market Size by Type (2015-2020)

　12.4 Central & South America mRNA Vaccines Market Size by Application (2015-2020)

13 Key Players Profiles

　13.1 Company 1

　　13.1.1 Company 1 Company Details

　　13.1.2 Company 1 Business Overview and Its Total Revenue

　　13.1.3 Company 1 mRNA Vaccines Introduction

　　13.1.4 Company 1 Revenue in mRNA Vaccines Business (2019-2020))

　　13.1.5 Company 1 Recent Development

　13.2 Company 2

　　13.2.1 Company 2 Company Details

　　13.2.2 Company 2 Business Overview and Its Total Revenue

　　13.2.3 Company 2 mRNA Vaccines Introduction

　　13.2.4 Company 2 Revenue in mRNA Vaccines Business (2019-2020))

　　13.2.5 Company 2 Recent Development

全球疫苗基因行業研究和趨勢報告二零二零至二六年

　13.3 Company 3

　　13.3.1 Company 3 Company Details

　　13.3.2 Company 3 Business Overview and Its Total Revenue

　　13.3.3 Company 3 mRNA Vaccines Introduction

　　13.3.4 Company 3 Revenue in mRNA Vaccines Business (2019-2020))

　　13.3.5 Company 3 Recent Development

　13.4 Company 4

　　13.4.1 Company 4 Company Details

　　13.4.2 Company 4 Business Overview and Its Total Revenue

　　13.4.3 Company 4 mRNA Vaccines Introduction

　　13.4.4 Company 4 Revenue in mRNA Vaccines Business (2019-2020))

　　13.4.5 Company 4 Recent Development

　13.5 Company 5

　　13.5.1 Company 5 Company Details

　　13.5.2 Company 5 Business Overview and Its Total Revenue

　　13.5.3 CureVaA Vaccines Introduction

　　13.5.4 Company 5 Revenue in mRNA Vaccines Business (2019-2020))

　　13.5.5 Company 5 Recent Development

　13.6 Company 6

　　13.6.1 Company 6 Company Details

　　13.6.2 Company 6 Business Overview and Its Total Revenue

　　13.6.3 Company 6 mRNA Vaccines Introduction

　　13.6.4 Company 6 Revenue in mRNA Vaccines Business (2019-2020))

　　13.6.5 Company 6 Recent Development

14 Market Dynamics

　14.1 Drivers

　14.2 Challenges

　14.3 Porter's Five Forces Analysis

　14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report

　15.1 Research Methodology

　　15.1.1 Methodology/Research Approach

　　15.1.2 Data Source

　15.2 Disclaimer

　15.3 Author Details

List of Tables

　Table 1. mRNA Vaccines Key Market Segments

　Table 2. Key Players Covered: Ranking by mRNA Vaccines Revenue

　Table 3. Ranking of Global Top mRNA Vaccines Manufacturers by Revenue (US$ Million) in 2019

　Table 4. Global mRNA Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

　Table 5. Key Players of Being Developed

　Table 6. Key Players of Preclinical

　Table 7. Key Players of Clinical I

　Table 8. Key Players of Clinical II

　Table 9. COVID-19 Impact Global Market: (Four mRNA Vaccines Market Size Forecast Scenarios)

　Table 10. Opportunities and Trends for mRNA Vaccines Players in the COVID-19 Landscape

　Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

　Table 12. Key Regions/Countries Measures against Covid-19 Impact

　Table 13. Proposal for mRNA Vaccines Players to Combat Covid-19 Impact

　Table 14. Global mRNA Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026

　Table 15. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026

　Table 16. Global mRNA Vaccines Market Size by Regions (US$ Million): 2020 VS 2026

　Table 17. Global mRNA Vaccines Market Share by Regions 2019-2026

　Table 18. Market Top Trends

　Table 19. Market Use Cases

　Table 20. Global mRNA Vaccines Revenue by Players (2019-2020) (Million US$)

　Table 21. Global mRNA Vaccines Market Share by Players (2019-2020)

　Table 22. Key Players Headquarters and Area Served

　Table 23. Key Players mRNA Vaccines Product Solution and Service

　Table 24. Date of Enter into mRNA Vaccines Market

　Table 25. Global Key Players mRNA Vaccines Funding/Investment Analysis (Million USD)

　Table 26. Global Key Players mRNA Vaccines Valuation & Market Capitalization (Million USD)

全球疫苗基因行業研究和趨勢報告二零二零至二六年

　Table 27. Mergers & Acquisitions, Expansion Plans

　Table 28. Global mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 29. Global mRNA Vaccines Market Size Share by Type (2019-2026)

　Table 30. Global mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 31. Global mRNA Vaccines Market Size Share by Application (2019-2026)

　Table 32. North America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 33. North America Key Players mRNA Vaccines Market Share (2019-2020)

　Table 34. North America mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 35. North America mRNA Vaccines Market Share by Type (2019-2026)

　Table 36. North America mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 37. North America mRNA Vaccines Market Share by Application (2019-2026)

　Table 38. Europe Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 39. Europe Key Players mRNA Vaccines Market Share (2019-2020)

　Table 40. Europe mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 41. Europe mRNA Vaccines Market Share by Type (2019-2026)

　Table 42. Europe mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 43. Europe mRNA Vaccines Market Share by Application (2019-2026)

　Table 44. China Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 45. China Key Players mRNA Vaccines Market Share (2019-2020)

　Table 46. China mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 47. China mRNA Vaccines Market Share by Type (2019-2026)

　Table 48. China mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 49. China mRNA Vaccines Market Share by Application (2019-2026)

　Table 50. Japan Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 51. Japan Key Players mRNA Vaccines Market Share (2019-2020)

　Table 52. Japan mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 53. Japan mRNA Vaccines Market Share by Type (2019-2026)

　Table 54. Japan mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 55. Japan mRNA Vaccines Market Share by Application (2019-2026)

　Table 56. Southeast Asia Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 57. Southeast Asia Key Players mRNA Vaccines Market Share (2019-2020)

　Table 58. Southeast Asia mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 59. Southeast Asia mRNA Vaccines Market Share by Type (2019-2026)

　Table 60. Southeast Asia mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 61. Southeast Asia mRNA Vaccines Market Share by Application (2019-2026)

　Table 62. India Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 63. India Key Players mRNA Vaccines Market Share (2019-2020)

　Table 64. India mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 65. India mRNA Vaccines Market Share by Type (2019-2026)

　Table 66. India mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 67. India mRNA Vaccines Market Share by Application (2019-2026)

　Table 68. Central & South America Key Players mRNA Vaccines Revenue (2019-2020) (Million US$)

　Table 69. Central & South America Key Players mRNA Vaccines Market Share (2019-2020)

　Table 70. Central & South America mRNA Vaccines Market Size by Type (2019-2026) (Million US$)

　Table 71. Central & South America mRNA Vaccines Market Share by Type (2019-2026)

　Table 72. Central & South America mRNA Vaccines Market Size by Application (2019-2026) (Million US$)

　Table 73. Central & South America mRNA Vaccines Market Share by Application (2019-2026)

　Table 74. Company 1 Company Details

　Table 75. Company 1 Business Overview

　Table 76. Company 1 Product

　Table 77. Company Description and Business Overview

　Table 78. Company 1 mRNA Vaccines Product

　Table 79. Company 1 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 80. Company 1 Recent Development

　Table 81. Company 2 Company Details

　Table 82. Company 2 Business Overview

　Table 83. Company 2 Product

　Table 84. Company Description and Business Overview

　Table 85. Company 2 mRNA Vaccines Product

　Table 86. Company 2 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 87. Company 2 Recent Development

　Table 88. Company 3 Company Details

quánqiú yìmiáo jīyīn hángyè yánjiū hé qūshì bàogào èr líng èr líng zhì èrliù nián

　Table 89. Company 3 Business Overview

　Table 90. Company 3 Product

　Table 91. Company Description and Business Overview

　Table 92. Company 3 mRNA Vaccines Product

　Table 93. Company 3 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 94. Company 3 Recent Development

　Table 95. Company 4 Company Details

　Table 96. Company 4 Business Overview

　Table 97. Company 4 Product

　Table 98. Company Description and Business Overview

　Table 99. Company 4 mRNA Vaccines Product

　Table 100. Company 4 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 101. Company 4 Recent Development

　Table 102. Company 5 Company Details

　Table 103. Company 5 Business Overview

　Table 104. Company 5 Product

　Table 105. Company Description and Business Overview

　Table 106. CureVaA Vaccines Product

　Table 107. Company 5 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 108. Company 5 Recent Development

　Table 109. Company 6 Company Details

　Table 110. Company 6 Business Overview

　Table 111. Company 6 Product

　Table 112. Company Description and Business Overview

　Table 113. Company 6 mRNA Vaccines Product

　Table 114. Company 6 Revenue in mRNA Vaccines Business 2019 and 2020 (Million US$)

　Table 115. Company 6 Recent Development

　Table 116. Company Description and Business Overview

　Table 117. Company Description and Business Overview

　Table 118. Company Description and Business Overview

　Table 119. Company Description and Business Overview

　Table 120. Company Description and Business Overview

　Table 121. Company Description and Business Overview

　Table 122. Company Description and Business Overview

　Table 123. Company Description and Business Overview

　Table 124. Company Description and Business Overview

　Table 125. Company Description and Business Overview

　Table 126. Company Description and Business Overview

　Table 127. Company Description and Business Overview

　Table 128. Company Description and Business Overview

　Table 129. Company Description and Business Overview

　Table 130. Company Description and Business Overview

　Table 131. Company Description and Business Overview

　Table 132. Company Description and Business Overview

　Table 133. Company Description and Business Overview

　Table 134. Company Description and Business Overview

　Table 135. Company Description and Business Overview

　Table 136. Company Description and Business Overview

　Table 137. Company Description and Business Overview

　Table 138. Company Description and Business Overview

　Table 139. Company Description and Business Overview

　Table 140. Company Description and Business Overview

　Table 141. Company Description and Business Overview

　Table 142. Company Description and Business Overview

　Table 143. Company Description and Business Overview

　Table 144. Company Description and Business Overview

　Table 145. Company Description and Business Overview

　Table 146. Company Description and Business Overview

　Table 147. Company Description and Business Overview

　Table 148. Company Description and Business Overview

　Table 149. Company Description and Business Overview

　Table 150. Key Drivers: Impact Analysis (2021-2026)

グローバルのmRNAワクチン業界の研究動向レポート2020-2026

　Table 151. Key Opportunities

　Table 152. Key Challenges

　Table 153. Research Programs/Design for This Report

　Table 154. Key Data Information from Secondary Sources

　Table 155. Key Data Information from Primary Sources

List of Figures

　Figure 1. Global mRNA Vaccines Market Share by Type: 2020 VS 2026

　Figure 2. Being Developed Features

　Figure 3. Preclinical Features

　Figure 4. Clinical I Features

　Figure 5. Clinical II Features

　Figure 6. Global mRNA Vaccines Market Share by Application: 2020 VS 2026

　Figure 7. COVID-19 Case Studies

　Figure 8. Cancer Case Studies

　Figure 9. Infectious Disease Treatment MRNA Vaccine Case Studies

　Figure 10. Infection Prevention MRNA Vaccine Case Studies

　Figure 11. mRNA Vaccines Report Years Considered

　Figure 12. Global mRNA Vaccines and Growth Rate (2019-2026) (Million US$)

　Figure 13. Global mRNA Vaccines Market Share by Regions (2019-2026)

　Figure 14. Global mRNA Vaccines Market Share by Players in 2019

　Figure 15. Global mRNA Vaccines Market Size Market Share by Type (2019-2026)

　Figure 16. Global mRNA Vaccines Market Size Market Share by Application (2019-2026)

　Figure 17. North America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 18. Europe mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 19. China mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 20. Japan mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 21. Southeast Asia mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 22. India mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 23. Central & South America mRNA Vaccines Market Size YoY Growth (2019-2026) (Million US$)

　Figure 24. Bottom-up and Top-down Approaches for This Report

　Figure 25. Data Triangulation

　Figure 26. Key Executives Interviewed

　　http://www.5269660.cn/7/83/Global-mRNA-Vaccines-Industry-Research-and-Trends-Report-2020-2026.html

　　……